The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...

Jabil Inc. has a 12-month low of $95.85 and a 12-month high of $174.80. The stock has a market capitalization of $17.84 billion, a price-to-earnings ratio of 15.67, a PEG ratio of 1.61 and a beta ...

The manufacturer has been exploring a sale since 2023. STORY HIGHLIGHTS Jabil Inc. acquired Pharmaceutics International Inc. on Feb. 3. Pharmaceutics operates a 360,000-square-foot campus in Hunt ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

Jabil on Tuesday revealed that it has purchased Hunt Valley, Maryland-based contract development and manufacturing organization Pharmaceutics International Inc. (Pii) for an undisclosed sum.

Meanwhile, Jabil’s market share has declined slightly from 5.3% in 2027 to 4.9% in 2024. We noted that Jabil’s revenue in 2024 has experienced the highest decline among competitors ...